Rhön-Klinikum starts PRO-HYPO randomized trial comparing hypofractionated proton vs IMRT radiation in prostate cancer
Bitget2026/10/14 10:58- Rhön-Klinikum announced recruitment has started for the randomized PRO-HYPO prostate cancer radiotherapy study at its Marburg ion-beam center.
- No results have been presented yet; the trial will track side effects, quality of life, and longer-term outcomes over five years.
- The study aims to determine whether hypofractionated proton therapy reduces bowel and bladder complications versus hypofractionated IMRT photon therapy.
- Enrollment targets 202 men with non-metastatic disease receiving radiation as primary treatment, supporting positioning for proton therapy capacity utilization.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.
Why Nintendo Stock Is One to Watch Ahead of the Holiday Season
A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.
Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.
Crypto prices
More
